Pathway inhibitors for bridging to allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL)

被引：0
|
作者：
Hahn, M. [1 ]
Dietrich, S. [1 ]
Hain, S-A [2 ]
Hegenbart, U. [1 ]
Rieger, M.
Scheuer, B.
Ho, A. D. [1 ]
Dreger, P. [1 ]
机构：
[1] Heidelberg Univ, Med Klin 5, Heidelberg, Germany
[2] St Marien Krankenhaus, Med Klin 3, Siegen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V61
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] Pathway inhibitors in the context of allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): a single center safety analysis
    Hahn, M.
    Dietrich, S.
    Goerner, M.
    Welslau, M.
    Kleinsorge, F.
    Rummel, M.
    Koehler, A.
    Zenz, T.
    Stilgenbauer, S.
    Ho, A. D.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S497 - S498
  • [2] Hematopoietic stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Horowitz, MM
    Montserrat, E
    Sobocinski, K
    Giralt, S
    Khouri, IF
    Schmitz, N
    BLOOD, 2000, 96 (11) : 522A - 522A
  • [3] Allogeneic stem cell transplantation for chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Bierman, PJ
    Tarantolo, SR
    Vose, JM
    Wu, D
    Reed, EC
    Pierson, JL
    Lynch, J
    Kessinger, A
    Armitage, JO
    Bishop, MR
    BLOOD, 1997, 90 (10) : 4508 - 4508
  • [4] ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN CHEMOTHERAPY REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Aljitawi, O. S.
    Krishnana, A.
    Nademance, A.
    Palmer, J.
    Alvarnas, J.
    Cai, J. -L.
    Kirschbaum, M.
    Kogut, N.
    Nakamura, R.
    Popplewell, L.
    Sarkodee-Adoo, C.
    Schriber, J.
    Zain, J.
    Parker, F.
    Forman, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 109 - 109
  • [5] Long term follow up of allogeneic hematopoietic stem cell transplantation (ASCT) in chronic lymphocytic leukemia (CLL).
    Malhotra, P
    Hogan, WJ
    Litzow, MR
    Elliott, MA
    Dispenzieri, A
    Call, T
    Kay, NE
    Zent, C
    Gastineau, DA
    Ansell, SM
    Hayman, S
    Gertz, MA
    Lacy, MQ
    Porrata, LF
    Inwards, DJ
    Tefferi, A
    BLOOD, 2005, 106 (11) : 441B - 441B
  • [6] Ibrutinib as salvage therapy for relapsed high-risk chronic lymphocytic leukemia (CLL) in patients after allogeneic hematopoietic stem cell transplantation (HSCT)
    Hahn, M.
    Dietrich, S.
    Goerner, M.
    Welslau, M.
    Zenz, T.
    Rummel, M.
    Schmitt, M.
    Koehler, A.
    Ho, A. D.
    Dreger, P.
    Oncology Research and Treatment, 2015, 38 : 93 - 93
  • [7] Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia
    Michallet, Mauricette
    Sobh, Mohamad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S19 - S20
  • [8] Outcome Of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Faderl, Stefan H.
    Shpall, Elizabeth J.
    Hosing, Chitra M.
    Khouri, Issa F.
    Champlin, Richard E.
    Keating, Michael J.
    Estrov, Zeev
    BLOOD, 2013, 122 (21)
  • [9] Outcome of Chronic Lymphocytic Leukemia (CLL) Patients That Failed Allogeneic Stem Cell Transplantation
    Benjamini, Ohad
    Rozovski, Uri
    Jain, Preetesh
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan
    Ferrajoll, Alessandra
    Faderl, Stefan
    Shpall, Elizabeth
    Hosing, Chitra
    Khouri, Issa F.
    Champlin, Richard
    Keating, Michael J.
    Estrov, Zeev
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S130 - S131
  • [10] Role of Allogeneic Hematopoietic Stem-Cell Transplantation in Chronic Lymphocytic Leukemia
    Gribben, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4864 - 4865
12345